It hasn’t been in many headlines (thanks, AI), but pharmaceutical companies are on a merger & acquisition spree that could break records. With more than $126 billion in deals so far this year, ...
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market This month’s US Supreme Court decision in Hikma v Amarin made waves in the IP ...
Tracing product flow Analyzing supplier dependencies Tracking supplier risks and dependency chains Understanding APIs (Active Pharmaceutical Ingredient) dependencies and connections Identifying risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results